How UBS AM dealt with Covid-19 crunch

Ben St. Clair
12 Aug 2020

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

This is the eighth in a series of articles connected to our buy-side risk survey. Click here to read the rest of the series.

Nasreen Kasenally started preparing her firm for a pandemic long before Covid-19 entered the global vocabulary.

When UBS Asset Management’s chief risk officer launched that work three years ago, she was not thinking about the spread of an incurable virus. Instead, she and her team had their eyes on a confluence of factors that would ultimately play a part in the stress

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]